Last Price$395.5(0.3%)
Market Cap$90.7B
3.2%
Peers median - 9.5%
2.6%
Peers median - 1.9%
4.9%
Peers median - 49.4%
161.3%
Peers median - 4.3%
Competing with ELV
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$90.7B | 6.7 | $1,001.8 153.3% undervalued | (20.5%) | $176.8B | $4,552.0M | 3.2% | 2.6% | 43.4% | 161.3% | 4.9% | |
$436.0B | 5.9 | $1,047.3 124.2% undervalued | (1.6%) | $398.3B | $20.7B | 8.4% | 5.2% | 21.9% | 28.1% | 1.5% | |
$87.2B | 5.8 | $942.9 202.7% undervalued | (6.0%) | $245.3B | $8,957.0M | 25.7% | 3.7% | 48.9% | 4.9% | 77.5% | |
$82.3B | 5.1 | $208.2 220.8% undervalued | (9.3%) | $372.8B | $6,326.0M | 4.2% | 1.7% | 13.8% | 3.7% | 109.5% | |
$31.5B | 6.1 | $797.8 205.0% undervalued | (23.7%) | $117.8B | $2,391.0M | 10.7% | 2.0% | 91.9% | 58.6% | 71.3% | |
$29.1B | 5.4 | $1,406.9 2,301.3% undervalued | (25.2%) | $163.1B | ($490.0M) | 5.9% | (0.3%) | 13.1% | 12.0% | 69.9% | |
$17.3B | 6.3 | $414.9 37.0% undervalued | (21.7%) | $40.6B | $544.0M | 19.2% | 1.3% | 34.7% | 33.0% | 69.4% | |
$3,703.3M | 6.1 | $23.7 57.0% undervalued | (1.7%) | $9,177.6M | $950.3M | 56.6% | 10.4% | 100.0% | (15.2%) | 29.5% | |
$3,104.9M | 5.4 | $8.2 47.0% overvalued | 187.4% | $2,703.6M | ($6,648.0K) | 48.3% | (0.2%) | 33.7% | (41.1%) | 7.8% | |
$1,871.6M | 5.2 | $2.0 45.3% overvalued | 330.8% | $1,370.6M | $128.3M | (32.4%) | 9.4% | 53.9% | 1.2% | 0.0% | |
$65.5M | 5.0 | $46.2 463.3% undervalued | (85.9%) | $1,616.6M | ($2,834.8M) | (71.1%) | (175.4%) | 7.8% | (63.3%) | (145.5%) |
Compare ELV Valuation Multiples with Peers
LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
General
Valuation Multiple
Financial metrics
Company name
EV/Revenue
Revenue growth
EBITDA margin
Net Income margin
Elevance Health Inc.ELV
0.5x
3.2%
(0.0%)
3.4%
Median Peer Set
0.4x
8.7%
(11.9%)
1.1%
Alignment Healthcare, Inc.ALHC
1.0x
27.2%
(4.8%)
(8.1%)
Bright Health Group, Inc.BHG
N/A
(51.9%)
86.2%
(103.4%)
Cigna CorporationCI
0.5x
8.4%
(18.9%)
2.6%
Clover Health Investments, Corp.CLOV
1.2x
(41.5%)
(31.3%)
(10.5%)
Centene CorporationCNC
0.2x
5.9%
27.4%
2.0%
CVS Health CorporationCVS
0.4x
4.2%
(43.6%)
1.2%
Humana Inc.HUM
0.2x
10.7%
(50.1%)
1.0%
Molina Healthcare, Inc.MOH
0.4x
19.3%
9.2%
2.9%
Oscar Health, Inc.OSCR
0.2x
56.5%
N/A
0.3%
UnitedHealth Group IncorporatedUNH
1.0x
8.9%
(35.7%)
3.6%
Compare ELV Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does Elevance Health Inc. (ELV) revenue growth compare to peers and the industry?
Elevance Health Inc. (ELV) revenue growth is 3.2%, compared to the peers' median of 9.5%.
2. How does Elevance Health Inc. (ELV) Free Cash Flow (FCF) margin compare to peers and the industry?
Elevance Health Inc. (ELV) FCF margin is 2.6%, compared to the peers' median of 1.9%.
3. How does Elevance Health Inc. (ELV) Total Debt to Equity ratio compare to peers and the industry?
Elevance Health Inc. (ELV) Total Debt to Equity ratio is 4.9%, compared to the peers' median of 49.4%.
4. How does Elevance Health Inc. (ELV) ROIC (Return on Invested Capital) compare to peers and the industry?
Elevance Health Inc. (ELV) ROIC is 161.3%, compared to the peers' median of 4.3%.